Toward pharmacologic therapy for glioblastoma: Characterization of the very long-chain acyl-CoA synthetase 3 (ACSVL3) inhibitor Grassofermata
Emily M. Clay, Xiaohai Shi, Elizabeth Anne Kolar, Yanqiu Liu, Bachchu Lal, Paul A. Watkins
This study identifies CB5 (grassofermata) as a potential inhibitor of ACSVL3, showing reduced glioma cell growth and malignancy in vitro and in vivo.
bioRxiv · Jul 8, 2026 · PreprintCancer Biology